BLEND 300 combines three fast-acting anabolic compounds—Trenbolone Acetate, Drostanolone Propionate, and Testosterone Propionate—each at 100mg/mL for time-sensitive, synergistic research applications. This formulation supports investigative work focused on androgen receptor dynamics and acute anabolic response in tissue-specific models.

The propionate and acetate esters used in this blend enable rapid uptake and clearance, allowing researchers to model peak hormone activity and short-cycle administration protocols. Each compound contributes uniquely to studies of protein synthesis, nitrogen retention, and hormonal signaling, with Trenbolone noted for high androgen binding affinity, Drostanolone for its non-aromatizing profile, and Testosterone as a baseline endogenous control.

Format: Sterile oil-based injectable solution, 300mg/mL total per vial
Purity: ≥98% (HPLC-verified)
Components: Trenbolone Acetate (100mg), Drostanolone Propionate (100mg), Testosterone Propionate (100mg)
Storage Recommendations: Store at 15°C–25°C; protect from light and heat
Intended Research Use: Acute androgen-response modeling, receptor synergy studies, pharmacokinetic analysis
For Research Use Only. Not for human consumption.